when will the semaglutide shortage end Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s The Semaglutide Shortage Is Ending:

Patients should seek prompt medical attention if they experience symptoms that may indicate worsening liver disease or a serious complication, including: Persistent fatigue or unexplained weight loss Yellowing of the skin or whites of the eyes (jaundice) Itching (pruritus), dark urine, or pale stools Swelling of the abdomen (ascites) Confusion or excessive drowsiness Vomiting blood or passing black, tarry stools Severe or persistent abdominal pain These symptoms require urgent clinical assessment

Effect of L-carnitine on the hepatic transcript profile in piglets as animal model

Injections Have Been a Barrier for Non-Users Nearly half of overweight Americans (49%) report having taken a GLP-1 for weight loss

Frequently asked questions Is retatrutide available in India in 2026